单位(元)广发医疗保健股票C(009163)利润表 |
报告期 |
2023/6/30 |
2022/12/31 |
2022/6/30 |
2021/12/31 |
收入 |
-1,301,135,473 |
-4,009,293,738 |
-2,030,079,587 |
-822,762,830 |
利息收入 |
1,478,807 |
3,242,029 |
1,701,656 |
3,457,787 |
其中:存款利息收入 |
1,478,807 |
3,242,029 |
1,701,656 |
3,411,918 |
债券利息收入 |
- |
- |
- |
14,396 |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
31,472 |
投资收益 |
-1,479,067,476 |
-1,864,975,290 |
-1,397,697,900 |
1,541,848,168 |
其中:股票投资收益 |
-1,531,518,967 |
-1,906,677,686 |
-1,424,976,523 |
1,505,005,183 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
-3,974,956 |
50,893 |
- |
1,249,772 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
56,426,447 |
41,651,503 |
27,278,623 |
35,593,213 |
公允价值变动收益 |
172,164,285 |
-2,163,957,040 |
-644,025,573 |
-2,435,880,324 |
汇兑收益 |
- |
- |
- |
- |
其他收入 |
4,288,911 |
16,396,562 |
9,942,231 |
67,811,538 |
费用 |
94,017,426 |
198,777,167 |
101,201,296 |
271,779,329 |
管理人报酬 |
77,510,405 |
164,050,173 |
83,691,463 |
198,811,402 |
托管费 |
12,918,401 |
27,341,696 |
13,948,577 |
33,135,234 |
销售服务费 |
3,442,666 |
7,117,881 |
3,429,149 |
5,332,882 |
交易费用 |
- |
- |
- |
34,224,239 |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
145,955 |
267,417 |
132,107 |
275,568 |
利润总额 |
-1,395,152,899 |
-4,208,070,906 |
-2,131,280,883 |
-1,094,542,160 |
减:所得税费用 |
- |
- |
- |
- |
净利润 |
-1,395,152,899 |
-4,208,070,906 |
-2,131,280,883 |
-1,094,542,160 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。